Tecan Group AG
🇨🇭XSWX.TECNSwitzerlandNot reported
PriceCHF 223.20-4.80 (-2.11%)
Latest anomalies
Neutral 1 detected in the last 120 days
- High: 8
- Medium: 0
- Low: 0
52-week high: the price is trading close to this level
Altman Z-score: a sudden drop below its trailing quarter average
Book to market ratio: a sudden spike above its trailing quarter average
Days sales outstanding: a sudden drop below its trailing quarter average
EV/sales: a sudden drop below its trailing quarter average
Free with a Finzer account.
Profile
- Switzerland
Identity
- Exchange
- SIX Swiss Exchange . XSWX
- Type
- Stock
- ISIN
- CH0012100191
- CUSIP
- Not reported
Company
- Employees
- 3,000
- Headquarters
- Männedorf, United Kingdom
- Website
- https://www.tecan.com
Market
- Shares outstanding
- 12.3M
- Market cap
- CHF 2.83B
Highlights
- Market cap
- CHF 2.9B
- EPS LTM
- CHF 10.58
- P/E LTM
- 37.76
- Div yield
- 1.42%
Fundamentals (LTM)
- Revenue
- CHF 1.37B+27.49%up year on year
- Net income
- CHF 135.27M+29.13%up year on year
- Gross margin
- 37.31%-3.65%down year on year
- Free cash flow
- CHF 131.16M+53.84%up year on year
Latest news
News is not sourced for this exchange.
Business summary
Tecan Group AG is listed on SIX Swiss Exchange (Switzerland) under the ticker TECN. Its market capitalisation is CHF 2.83B, from 12.3M shares outstanding, as of . Across the 249 trading sessions to the shares traded between CHF 110.60 and CHF 229.60, and the last close of CHF 223.20 sits 95% of the way up that range. The company is headquartered in Männedorf, United Kingdom, and employs about 3,000 people. The same company also trades as 0QLN on London Stock Exchange.
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized OEM system; Cavro, a standard and customized OEM component; and onsite and depot repairs, as well as remote services and digital solutions. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.